RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)
26 janv. 2021 02h30 HE
|
Curium
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a...
QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
21 janv. 2021 09h00 HE
|
QSAM Biosciences Inc.
Palm Beach, FL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines for the treatment of cancer and related diseases and...
Global Radiopharmaceuticals Market Trajectory & Analytics, 2020-2027 - Distribution Bottlenecks amid COVID-19 Crisis Leave Hospitals Struggling with Seamless Supply of Medical Radioisotopes
08 janv. 2021 09h28 HE
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Sharp Decline in Patient...
United States Prostate Cancer Nuclear Medicine Diagnostics Market Outlook to 2027 - A US$ 431.76 Million Market by 2027
28 déc. 2020 13h23 HE
|
Research and Markets
Dublin, Dec. 28, 2020 (GLOBE NEWSWIRE) -- The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to...
QSAM Biosciences Issues Letter from New CEO; Presents Opportunities Ahead for Company
24 nov. 2020 09h00 HE
|
QSAM Biosciences Inc.
Palm Beach, FL, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The recently appointed Chief Executive Officer of QSAM Biosciences Inc. (OTCQB: QSAM), Douglas Baum, provided in the following letter to...
Insights on the Worldwide Nuclear Medicine Market to 2025 - Featuring GE Healthcare, Siemens Healthineers & Rotem Industries Among Others
13 nov. 2020 07h08 HE
|
Research and Markets
Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET, Alpha-emitters, Beta-emitters,...
Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Report 2020-2030: Current Market Landscape and Potential of Companies Having the Xapabilities to Manufacture Radiopharmaceuticals
12 oct. 2020 03h04 HE
|
Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The 'Nuclear...
QSAM Biosciences Starts Trading under New Symbol: QSAM
09 oct. 2020 09h00 HE
|
QSAM Biosciences Inc.
Palm Beach, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM) announced today that it has commenced trading on The OTC Markets under the new stock symbol QSAM. The company’s...
Global Nuclear Medicine/Radiopharmaceuticals Market Report 2020-2027
02 oct. 2020 04h34 HE
|
Research and Markets
Dublin, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast To 2027" report has been added to ResearchAndMarkets.com's offering. The nuclear...
Curium Announces Approval of Pulmotech™ MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
24 mars 2020 02h00 HE
|
Curium
St. Louis, MO, March 24, 2020 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration (FDA) has approved Pulmotech MAA. When labeled to technetium Tc 99m, Pulmotech...